Five Star Equities Issues New Research Reports on EGO, PGNX, PHM and SLTM

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Eldorado Gold Corp. (NYSE:EGO - News)(TSX:ELD.TO - News) shares declined 9.02 percent to close at $6.15 a share Thursday. The stock traded between $6.01 and $6.57 on volume of 10.71 million shares traded. Gold Miners fell sharply Thursday as gold prices fell to a 2 and ½ year low after the Federal Reserve signaled it would begin to cut back on stimulus measures. Shares of Eldorado Gold have fallen approximately 36.0 percent year-to-date.

Get more information on Eldorado Gold and free access to the in-depth equity report at:
www.FiveStarEquities.com/EGO

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX - News) shares declined 10.83 percent to close at $4.28 a share Thursday. The stock traded between $4.10 and $4.40 on volume of 3.35 million shares traded. The company announced the pricing of a public offering of 8.5 million shares of its common stock at $4.40 per share, a discount of 8.3 percent to Wednesday’s close. Shares of Progenics Pharmaceuticals have gained approximately 43.6 percent year-to-date.

Get more information on Progenics Pharmaceuticals and free access to the in-depth equity report at:
www.FiveStarEquities.com/PGNX

PulteGroup, Inc. (NYSE:PHM - News) shares declined 9.10 percent to close at $18.87 a share Thursday. The stock traded between $18.33 and $20.19 on volume of 28.40 million shares traded. Homebuilders across the board fell Thursday on concerns that the curbing of stimulus measures by the Federal Reserve would cause sharp increase in mortgage rates. Shares of the PulteGroup have fallen approximately 12.9 percent year-to-date.

Get more information on PulteGroup and free access to the in-depth equity report at:
www.FiveStarEquities.com/PHM

Solta Medical Inc. (NASDAQ:SLTM - News) shares gained 1.79 percent to close at $2.27 a share Thursday. The stock traded between $2.25 and $2.45 on volume of 566,002 shares traded. The company announced that its Fraxel DUAL 1550/1927 laser system has received a new FDSA clearance for the treatment of pigmented lesions. Shares of Solta Medical have fallen approximately 15.0 percent year-to-date.

Get more information on Solta Medical and free access to the in-depth equity report at:
www.FiveStarEquities.com/SLTM

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com